Literature DB >> 24780460

Glycemic exposure, glycemic control, and metabolic karma in diabetic complications.

Merlin C Thomas1.   

Abstract

Diabetes continues to cast a long shadow over the lives of many people. It is now clear that even transient hyper- or hypoglycemia or increased glycemic variability around healthy mean glucose levels can have long-lasting and long-term effects on the development and progression of diabetic complications, including cardiovascular disease, kidney disease, retinopathy, and neuropathy. Even after glycemic control has been achieved and maintained for many years, it appears hard to undo the changes that are instilled, including epigenetic programming, compositional changes, post-translational modifications, or simply lead time toward an inevitable fate. This phenomenon has become known as "metabolic memory" or the "legacy effect," but it may be better characterized as "metabolic karma," in which the intent and actions of an individual (with respect to metabolic control) influence the future health of that individual. This "bad karma" has been used to explain many clinical observations surrounding diabetes and its management, including the lack of benefits in many short- and intermediate-term trials, and the potential utility of early intensive glycemic control. Further understanding the molecular basis of a metabolic legacy in diabetes will certainly provide new targets for intervention.
Copyright © 2014 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Diabetes; Diabetic nephropathy; Epigenetics; Legacy; Memory

Mesh:

Substances:

Year:  2014        PMID: 24780460     DOI: 10.1053/j.ackd.2014.03.004

Source DB:  PubMed          Journal:  Adv Chronic Kidney Dis        ISSN: 1548-5595            Impact factor:   3.620


  12 in total

1.  Elevated Glucose Levels Promote Contractile and Cytoskeletal Gene Expression in Vascular Smooth Muscle via Rho/Protein Kinase C and Actin Polymerization.

Authors:  Tran Thi Hien; Karolina M Turczyńska; Diana Dahan; Mari Ekman; Mario Grossi; Johan Sjögren; Johan Nilsson; Thomas Braun; Thomas Boettger; Eliana Garcia-Vaz; Karin Stenkula; Karl Swärd; Maria F Gomez; Sebastian Albinsson
Journal:  J Biol Chem       Date:  2015-12-18       Impact factor: 5.157

2.  Oral Azelaic Acid Ester Decreases Markers of Insulin Resistance in Overweight Human Male Subjects.

Authors:  Robert T Streeper; Elzbieta Izbicka; Christopher Louden
Journal:  In Vivo       Date:  2020 May-Jun       Impact factor: 2.155

Review 3.  Epigenetic Mechanisms in Diabetic Kidney Disease.

Authors:  Merlin C Thomas
Journal:  Curr Diab Rep       Date:  2016-03       Impact factor: 4.810

Review 4.  Biomarkers in Diabetic Retinopathy.

Authors:  Alicia J Jenkins; Mugdha V Joglekar; Anandwardhan A Hardikar; Anthony C Keech; David N O'Neal; Andrzej S Januszewski
Journal:  Rev Diabet Stud       Date:  2015-08-10

Review 5.  Management of diabetes mellitus in individuals with chronic kidney disease: therapeutic perspectives and glycemic control.

Authors:  Carolina C R Betônico; Silvia M O Titan; Maria Lúcia C Correa-Giannella; Márcia Nery; Márcia Queiroz
Journal:  Clinics (Sao Paulo)       Date:  2016-01       Impact factor: 2.365

6.  Diabetes Destiny in our Hands: Achieving Metabolic Karma.

Authors:  Sanjay Kalra; Jignesh Ved; Manash P Baruah
Journal:  Indian J Endocrinol Metab       Date:  2017 May-Jun

7.  Transgenerational Karma.

Authors:  Bharti Kalra; Sanjay Kalra; A G Unnikrishnan; Manash P Baruah; Deepak Khandelwal; Yashdeep Gupta
Journal:  Indian J Endocrinol Metab       Date:  2017 Mar-Apr

Review 8.  Bedside-to-Bench Translational Research for Chronic Heart Failure: Creating an Agenda for Clients Who Do Not Meet Trial Enrollment Criteria.

Authors:  P Iyngkaran; M Thomas
Journal:  Clin Med Insights Cardiol       Date:  2015-08-05

9.  Differences in glycemic control across world regions: a post-hoc analysis in patients with type 2 diabetes mellitus on dual antidiabetes drug therapy.

Authors:  H Brath; P M Paldánius; G Bader; W M Kolaczynski; P M Nilsson
Journal:  Nutr Diabetes       Date:  2016-07-04       Impact factor: 5.097

Review 10.  Clinical predictive factors in diabetic kidney disease progression.

Authors:  Nicholas J Radcliffe; Jas-Mine Seah; Michele Clarke; Richard J MacIsaac; George Jerums; Elif I Ekinci
Journal:  J Diabetes Investig       Date:  2016-06-08       Impact factor: 4.232

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.